An integrated strategy for holistic quality identification of Chinese patent medicine: Liuwei Dihuang Pills as a case study

Volume: 32, Issue: 2, Pages: 183 - 197
Published: Mar 4, 2020
Abstract
Introduction Liuwei Dihuang Pills (concentrated pills, simplified as LWDHP), one of the most famous classic Chinese Patent Medicine (CPM), is produced by hundreds of pharmaceutical manufacturers with billions of Chinese yuan (CNY) in annual sales. However, current quality identification of LWDHP mainly relies on a thin-layer chromatography (TLC) method that is complicated and deficient. Objective The goal of this study is to simplify the...
Paper Details
Title
An integrated strategy for holistic quality identification of Chinese patent medicine: Liuwei Dihuang Pills as a case study
Published Date
Mar 4, 2020
Volume
32
Issue
2
Pages
183 - 197
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.